{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:38:45Z","timestamp":1790771925593,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,6,29]],"date-time":"2005-06-29T00:00:00Z","timestamp":1120003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s00401-005-1027-3","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T18:35:14Z","timestamp":1119983714000},"page":"135-144","source":"Crossref","is-referenced-by-count":47,"title":["Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and \u03b1-synuclein pathology"],"prefix":"10.1007","volume":"110","author":[{"given":"Jodie","family":"Newman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Rissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floyd","family":"Sarsoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl W.","family":"Cotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy T.","family":"Rohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,6,29]]},"reference":[{"key":"1027_CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.10793","volume":"55","author":"Arai","year":"2004","unstructured":"Arai T, Ikeda K, Akiyama H, Nonaka T, Hasegawa M, Ishiguro K, Iritani S, Tsuchiya K, Iseki E, Yagishita S, Oda T, Mochizuki A (2004) Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol 55:72\u201379","journal-title":"Ann Neurol"},{"key":"1027_CR2","first-page":"879","volume":"152","author":"Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 152:879\u2013884","journal-title":"Am J Pathol"},{"key":"1027_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0896-6273(93)90279-Z","volume":"11","author":"Biernat","year":"1993","unstructured":"Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E (1993) Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11:153\u2013163","journal-title":"Neuron"},{"key":"1027_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"Braak","year":"1995","unstructured":"Braak H, Braak E (1995) Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging 16:271\u2013284","journal-title":"Neurobiol Aging"},{"key":"1027_CR5","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","volume":"10","author":"Bramblett","year":"1993","unstructured":"Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM-Y (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer\u2019s disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089\u20131099","journal-title":"Neuron"},{"key":"1027_CR6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0006-8993(95)00535-X","volume":"696","author":"Castellani","year":"1995","unstructured":"Castellani R, Smith MA, Richey PL, Kalaria R, Gambetti P, Perry G (1995) Evidence for oxidative stress in Pick disease and corticobasal degeneration. Brain Res 696:268\u2013271","journal-title":"Brain Res"},{"key":"1027_CR7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(96)00729-9","volume":"737","author":"Castellani","year":"1996","unstructured":"Castellani R, Smith M, Richey P, Perry G (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 737:195\u2013200","journal-title":"Brain Res"},{"key":"1027_CR8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO;2-E","volume":"58","author":"Clayton","year":"1999","unstructured":"Clayton DF, George JM (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res 58:120\u2013129","journal-title":"J Neurosci Res"},{"key":"1027_CR9","first-page":"1388","volume":"146","author":"Feany","year":"1995","unstructured":"Feany MB, Dickson DW (1995) Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146:1388\u20131396","journal-title":"Am J Pathol"},{"key":"1027_CR10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2990.2001.00348.x","volume":"27","author":"Ferrer","year":"2001","unstructured":"Ferrer I, Blanco R, Carmona M, Puig B (2001) Phosphorylated c-MYC expression in Alzheimer disease, Pick\u2019s disease, progressive supranuclear palsy and corticobasal degeneration. Neuropathol Appl Neurobiol 27:343\u2013351","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1027_CR11","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0002-9440(10)61154-6","volume":"160","author":"Forman","year":"2002","unstructured":"Forman MS, Zhukareva V, Bergeron C, Chin SS, Grossman M, Clark C, Lee VM, Trojanowski JQ (2002) Signature tau neuropathology in gray and white matter of corticobasal degeneration. Am J Pathol 160:2045\u20132053","journal-title":"Am J Pathol"},{"key":"1027_CR12","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.1630428100","volume":"100","author":"Gamblin","year":"2003","unstructured":"Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 100:10032\u201310037","journal-title":"Proc Natl Acad Sci USA"},{"key":"1027_CR13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.44.6.1015","volume":"44","author":"Gearing","year":"1994","unstructured":"Gearing M, Olson DA, Watts RL, Mirra SS (1994) Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 44:1015\u20131024","journal-title":"Neurology"},{"key":"1027_CR14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000051220","volume":"10","author":"Gerst","year":"1999","unstructured":"Gerst JL, Siedlak SL, Nunomura A, Castellani R, Perry G, Smith MA (1999) Role of oxidative stress in frontotemporal dementia. Dement Geriatr Cogn Disord 10:85\u201387","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1027_CR15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.2000.tb06905.x","volume":"920","author":"Ghetti","year":"2000","unstructured":"Ghetti B, Murrell JR, Zolo P, Spillantini MG, Goedert M (2000) Progress in hereditary tauopathies: a mutation in the Tau gene (G389R) causes a Pick disease-like syndrome. Ann N Y Acad Sci 920:52\u201362","journal-title":"Ann N Y Acad Sci"},{"key":"1027_CR16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1385\/JMN:20:2:203","volume":"20","author":"Hardy","year":"2003","unstructured":"Hardy J (2003) The relationship between amyloid and tau. J Mol Neurosci 20:203\u2013206","journal-title":"J Mol Neurosci"},{"key":"1027_CR17","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1023\/A:1026073324672","volume":"28","author":"Hashimoto","year":"2003","unstructured":"Hashimoto M, Masliah E (2003) Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer\u2019s and dementia with Lewy bodies. Neurochem Res 28:1743\u20131756","journal-title":"Neurochem Res"},{"key":"1027_CR18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0304-3940(90)90829-X","volume":"119","author":"Hauw","year":"1990","unstructured":"Hauw JJ, Verny M, Delaere P, Cervera P, He Y, Duyckaerts C (1990) Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer\u2019s disease and aging. Neurosci Lett 119:182\u2013186","journal-title":"Neurosci Lett"},{"key":"1027_CR19","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1212\/WNL.56.suppl_4.S6","volume":"56","author":"Hodges","year":"2001","unstructured":"Hodges JR (2001) Frontotemporal dementia (Pick\u2019s disease): clinical features and assessment. Neurology 56: S6\u201310","journal-title":"Neurology"},{"key":"1027_CR20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00401-003-0734-x","volume":"106","author":"Hogg","year":"2003","unstructured":"Hogg M, Grujic ZM, Baker M, Demirci S, Guillozet AL, Sweet AP, Herzog LL, Weintraub S, Mesulam MM, LaPointe NE, Gamblin TC, Berry RW, Binder LI, Silva R de, Lees A, Espinoza M, Davies P, Grover A, Sahara N, Ishizawa T, Dickson D, Yen SH, Hutton M, Bigio EH (2003) The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy. Acta Neuropathol 106:323\u2013336","journal-title":"Acta Neuropathol"},{"key":"1027_CR21","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0197-4580(98)00034-7","volume":"19","author":"Ikeda","year":"1998","unstructured":"Ikeda K, Akiyama H, Arai T, Nishimura T (1998) Glial tau pathology in neurodegenerative diseases: their nature and comparison with neuronal tangles. Neurobiol Aging 19: S85\u201391","journal-title":"Neurobiol Aging"},{"key":"1027_CR22","doi-asserted-by":"crossref","unstructured":"Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW (2003) Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol. 62:389\u2013397","DOI":"10.1093\/jnen\/62.4.389"},{"key":"1027_CR23","first-page":"95","volume":"59","author":"Jellinger","year":"2000","unstructured":"Jellinger KA, Stadelmann C (2000) Mechanisms of cell death in neurodegenerative disorders. J Neural Transm Suppl 59:95\u2013114","journal-title":"J Neural Transm Suppl"},{"key":"1027_CR24","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1023\/A:1026061021946","volume":"28","author":"Klucken","year":"2003","unstructured":"Klucken J, McLean PJ, Gomez-Tortosa E, Ingelsson M, Hyman BT (2003) Neuritic alterations and neural system dysfunction in Alzheimer\u2019s disease and dementia with Lewy bodies. Neurochem Res 28:1683\u20131691","journal-title":"Neurochem Res"},{"key":"1027_CR25","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1074\/jbc.M311203200","volume":"279","author":"Krishnamurthy","year":"2004","unstructured":"Krishnamurthy PK, Johnson GV (2004) Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model. J Biol Chem 279:7893\u20137900","journal-title":"J Biol Chem"},{"key":"1027_CR26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"Lee","year":"2001","unstructured":"Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121\u20131159","journal-title":"Annu Rev Neurosci"},{"key":"1027_CR27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00401-004-0900-9","volume":"108","author":"Lipton","year":"2004","unstructured":"Lipton AM, White CL 3rd, Bigio EH (2004) Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol 108:379\u2013385","journal-title":"Acta Neuropathol"},{"key":"1027_CR28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"McKeith","year":"1996","unstructured":"McKeith IG, Galaski D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe DM, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, Vos RAI de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clincial and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47:1113\u20131124","journal-title":"Neurology"},{"key":"1027_CR29","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","volume":"58","author":"McKhann","year":"2001","unstructured":"McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ (2001) Clinical and pathological diagnosis of frontotemporal dementia: Report of the work group on frontotemporal dementia and Pick\u2019s disease. Arch Neurol 58:1803\u20131809","journal-title":"Arch Neurol"},{"key":"1027_CR30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"1027_CR31","first-page":"641","volume":"24","author":"Morris","year":"1988","unstructured":"Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A (1988) Consortium to establish a registry for Alzheimer\u2019s disease (CERAD) clinical and neuropsychological assessment of Alzheimer\u2019s disease. Psychopharmacol Bull 24:641\u2013652","journal-title":"Psychopharmacol Bull"},{"key":"1027_CR32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.2000.tb06904.x","volume":"920","author":"Neary","year":"2000","unstructured":"Neary D, Snowden JS, Mann DM (2000) Classification and description of frontotemporal dementias. Ann N Y Acad Sci 920:46\u201351","journal-title":"Ann N Y Acad Sci"},{"key":"1027_CR33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ana.1223","volume":"50","author":"Neumann","year":"2001","unstructured":"Neumann M, Schulz-Schaeffer W, Crowther RA, Smith MJ, Spillantini MG, Goedert M, Kretzschmar HA (2001) Pick\u2019s disease associated with the novel Tau gene mutation K369I. Ann Neurol 50:503\u2013513","journal-title":"Ann Neurol"},{"key":"1027_CR34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/1531-8249(200012)48:6<859::AID-ANA6>3.0.CO;2-1","volume":"48","author":"Pickering-Brown","year":"2000","unstructured":"Pickering-Brown S, Baker M, Yen SH, Liu WK, Hasegawa M, Cairns N, Lantos PL, Rossor M, Iwatsubo T, Davies Y, Allsop D, Furlong R, Owen F, Hardy J, Mann D, Hutton M (2000) Pick\u2019s disease is associated with mutations in the tau gene. Ann Neurol 48:859\u2013867","journal-title":"Ann Neurol"},{"key":"1027_CR35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1749-6632.2002.tb02086.x","volume":"959","author":"Pollack","year":"2002","unstructured":"Pollack M, Phaneuf S, Dirks A, Leeuwenburgh C (2002) The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann N Y Acad Sci 959:93\u2013107","journal-title":"Ann N Y Acad Sci"},{"key":"1027_CR36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s004010050565","volume":"92","author":"Probst","year":"1996","unstructured":"Probst A, Tolnay M, Langui D, Goedert M, Spillantini MG (1996) Pick\u2019s disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol 92:588\u2013596","journal-title":"Acta Neuropathol"},{"key":"1027_CR37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200420640","volume":"114","author":"Rissman","year":"2004","unstructured":"Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 114:121\u2013130","journal-title":"J Clin Invest"},{"key":"1027_CR38","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jnen\/59.11.990","volume":"59","author":"Rizzini","year":"2000","unstructured":"Rizzini C, Goedert M, Hodges JR, Smith MJ, Jakes R, Hills R, Xuereb JH, Crowther RA, Spillantini MG (2000) Tau gene mutation K257T causes a tauopathy similar to Pick\u2019s disease. J Neuropathol Exp Neurol 59:990\u20131001","journal-title":"J Neuropathol Exp Neurol"},{"key":"1027_CR39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9440(10)63957-0","volume":"158","author":"Rohn","year":"2001","unstructured":"Rohn TT, Head E, Su JH, Anderson AJ, Bahr BA, Cotman CW, Cribbs DH (2001) Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer\u2019s disease. Am J Pathol 158:189\u2013198","journal-title":"Am J Pathol"},{"key":"1027_CR40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/nbdi.2002.0549","volume":"11","author":"Rohn","year":"2002","unstructured":"Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E (2002) Caspase-9 activation and caspase cleavage of tau in the Alzheimer\u2019s disease brain. Neurobiol Dis 11:341\u2013354","journal-title":"Neurobiol Dis"},{"key":"1027_CR41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1358\/dnp.2002.15.9.740233","volume":"15","author":"Rohn","year":"2002","unstructured":"Rohn TT, Rissman RA, Head E, Cotman CW (2002) Caspase activation in the Alzheimer\u2019s disease brain: tortuous and torturous. Drug News Perspect 15:549\u2013557","journal-title":"Drug News Perspect"},{"key":"1027_CR42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.10140","volume":"51","author":"Rosso","year":"2002","unstructured":"Rosso SM, Herpen E van, Deelen W, Kamphorst W, Severijnen LA, Willemsen R, Ravid R, Niermeijer MF, Dooijes D, Smith MJ, Goedert M, Heutink P, Swieten JC van (2002) A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick\u2019s disease. Ann Neurol 51:373\u2013376","journal-title":"Ann Neurol"},{"key":"1027_CR43","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnen\/60.9.829","volume":"60","author":"Roth","year":"2001","unstructured":"Roth KA (2001) Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol 60:829\u2013838","journal-title":"J Neuropathol Exp Neurol"},{"key":"1027_CR44","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00005072-199909000-00012","volume":"58","author":"Selznick","year":"1999","unstructured":"Selznick LA, Holtzman DM, Han BH, Gokden M, Srinivasan AN, Johnson EM Jr, Roth KA (1999) In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J Neuropathol Exp Neurol 58:1020\u20131026","journal-title":"J Neuropathol Exp Neurol"},{"key":"1027_CR45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"1027_CR46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1750-3639.1998.tb00162.x","volume":"8","author":"Spillantini","year":"1998","unstructured":"Spillantini MG, Bird TD, Ghetti B (1998) Frontotemporal dementia and parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol 8:387\u2013402","journal-title":"Brain Pathol"},{"key":"1027_CR47","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/brain\/awg090","volume":"126","author":"Stanford","year":"2003","unstructured":"Stanford PM, Shepherd CE, Halliday GM, Brooks WS, Schofield PW, Brodaty H, Martins RN, Kwok JB, Schofield PR (2003) Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 126:814\u2013826","journal-title":"Brain"},{"key":"1027_CR48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","volume":"10","author":"Steele","year":"1964","unstructured":"Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333\u2013359","journal-title":"Arch Neurol"},{"key":"1027_CR49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2990.1999.00182.x","volume":"25","author":"Tolnay","year":"1999","unstructured":"Tolnay M, Probst A (1999) Review: tau protein pathology in Alzheimer\u2019s disease and related disorders. Neuropathol Appl Neurobiol 25:171\u2013187","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1027_CR50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00310383","volume":"88","author":"Uchihara","year":"1994","unstructured":"Uchihara T, Mitani K, Mori H, Kondo H, Yamada M, Ikeda K (1994) Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer\u2019s disease or progressive supranuclear palsy. Acta Neuropathol 88:379\u2013383","journal-title":"Acta Neuropathol"},{"key":"1027_CR51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00495299","volume":"83","author":"Wang","year":"1985","unstructured":"Wang B, Larson L (1985) Simultaneous demonstration of multiple antigens by indirect immunofluorescence or immunogold staining. Histochemistry 83:47\u201356","journal-title":"Histochemistry"},{"key":"1027_CR52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0098-2997(03)00024-4","volume":"24","author":"Zarkovic","year":"2003","unstructured":"Zarkovic K (2003) 4-Hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 24:293\u2013303","journal-title":"Mol Aspects Med"},{"key":"1027_CR53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1044-7431(03)00175-1","volume":"24","author":"Zhao","year":"2003","unstructured":"Zhao Z, Ho L, Suh J, Qin W, Pyo H, Pompl P, Ksiezak-Reding H, Pasinetti GM (2003) A role of P301L tau mutant in anti-apoptotic gene expression, cell cycle and apoptosis. Mol Cell Neurosci 24:367\u2013379","journal-title":"Mol Cell Neurosci"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-005-1027-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-005-1027-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-005-1027-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:23:02Z","timestamp":1559064182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-005-1027-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,29]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["1027"],"URL":"https:\/\/doi.org\/10.1007\/s00401-005-1027-3","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,29]]}}}